ZA764726B - Analogs of neamine - Google Patents

Analogs of neamine

Info

Publication number
ZA764726B
ZA764726B ZA764726A ZA764726A ZA764726B ZA 764726 B ZA764726 B ZA 764726B ZA 764726 A ZA764726 A ZA 764726A ZA 764726 A ZA764726 A ZA 764726A ZA 764726 B ZA764726 B ZA 764726B
Authority
ZA
South Africa
Prior art keywords
neamine
analogs
Prior art date
Application number
ZA764726A
Other languages
English (en)
Inventor
B Magerlein
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of ZA764726B publication Critical patent/ZA764726B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/224Cyclohexane rings substituted by at least two nitrogen atoms with only one saccharide radical directly attached to the cyclohexyl radical, e.g. destomycin, fortimicin, neamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ZA764726A 1975-09-08 1976-08-05 Analogs of neamine ZA764726B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/611,349 US3996205A (en) 1975-09-08 1975-09-08 Aminoglycoside antibiotics and intermediates

Publications (1)

Publication Number Publication Date
ZA764726B true ZA764726B (en) 1977-07-27

Family

ID=24448676

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA764726A ZA764726B (en) 1975-09-08 1976-08-05 Analogs of neamine

Country Status (14)

Country Link
US (1) US3996205A (xx)
JP (1) JPS5233649A (xx)
AU (1) AU506262B2 (xx)
BE (1) BE845942A (xx)
CA (1) CA1067899A (xx)
CH (1) CH626896A5 (xx)
DE (1) DE2638794A1 (xx)
FR (2) FR2322608A1 (xx)
GB (1) GB1530643A (xx)
HU (1) HU177271B (xx)
NL (1) NL7609874A (xx)
PL (1) PL111474B1 (xx)
SU (1) SU700066A3 (xx)
ZA (1) ZA764726B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182855A (en) * 1977-05-05 1980-01-08 The Upjohn Company Nitrosugar
US7794713B2 (en) 2004-04-07 2010-09-14 Lpath, Inc. Compositions and methods for the treatment and prevention of hyperproliferative diseases
WO2007113841A2 (en) * 2006-04-03 2007-10-11 Technion Research & Development Foundation Ltd. Novel aminoglycosides and uses thereof in the treatment of genetic disorders
US7862812B2 (en) 2006-05-31 2011-01-04 Lpath, Inc. Methods for decreasing immune response and treating immune conditions
WO2017037717A1 (en) 2015-09-02 2017-03-09 Eloxx Pharmaceuticals Ltd. Aminoglycoside derivatives and uses thereof in treating genetic disorders
WO2017037718A1 (en) 2015-09-02 2017-03-09 Eloxx Pharmaceuticals Ltd. Aminoglycoside derivatives and uses thereof in treating genetic disorders
US10899785B2 (en) 2015-09-02 2021-01-26 Eloxx Pharmaceuticals Ltd. Aminoglycoside derivatives and uses thereof in treating genetic disorders
US11136345B2 (en) 2017-03-15 2021-10-05 Eloxx Pharmaceuticals Ltd. Large scale preparation of pseudo-trisaccharide aminoglycosides and of intermediates thereof
EP3883943A4 (en) 2018-11-22 2023-01-04 Technion Research & Development Foundation Limited MODIFIED AMINOGLYCOSIDE COMPOUNDS AND THEIR USES TO DEACTIVATE BACTERIAL RIBOSOMES

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH84A (fr) * 1889-01-10 Fontainemelon Horlogerie Perfectionnement apporté dans la construction des mécanismes de remontoir des montres de tous calibres
JPS507595B1 (xx) * 1970-07-29 1975-03-27
US3792037A (en) * 1971-11-04 1974-02-12 Bristol Myers Co Process for preparing ambutyrosin
CA992535A (en) * 1972-03-08 1976-07-06 Bristol-Myers Squibb Company Antibiotic derivatives
US3897412A (en) * 1972-05-04 1975-07-29 Bristol Myers Co Paromomycin antibiotic derivatives
US3860574A (en) * 1972-12-06 1975-01-14 Bristol Myers Co Derivatives of neomycin b and neomycin c
US3886139A (en) * 1973-02-23 1975-05-27 Bristol Myers Co Derivatives of kanamycin
US3893997A (en) * 1974-07-01 1975-07-08 Smithkline Corp Pseudodisaccharide intermediates

Also Published As

Publication number Publication date
US3996205A (en) 1976-12-07
SU700066A3 (ru) 1979-11-25
GB1530643A (en) 1978-11-01
BE845942A (fr) 1977-03-08
FR2355852A1 (fr) 1978-01-20
AU1662676A (en) 1978-02-09
CH626896A5 (xx) 1981-12-15
HU177271B (en) 1981-08-28
PL111474B1 (en) 1980-08-30
FR2355852B1 (xx) 1980-04-04
NL7609874A (nl) 1977-03-10
FR2322608B1 (xx) 1979-09-07
FR2322608A1 (fr) 1977-04-01
JPS5233649A (en) 1977-03-14
PL192253A1 (pl) 1979-02-26
CA1067899A (en) 1979-12-11
DE2638794A1 (de) 1977-03-10
AU506262B2 (en) 1979-12-20

Similar Documents

Publication Publication Date Title
PH13279A (en) Novel dosage forms
JPS51127809A (en) Composition of ink
PH13712A (en) Novel dosage forms
ZA763765B (en) 13-cis-pg analogs
ZA76113B (en) Novel nucleoside compounds
JPS5268104A (en) Symmetric bisscarbamate compounds
JPS5236632A (en) Composition containing impurityydecreasing bissbiguanide
JPS5251330A (en) Preparation of trichloromethyll trifluoromethyllbenzene
JPS51131836A (en) Preparation of acetoacetylarylamide
JPS51115427A (en) Preparation of ethylbenzole
ZA764726B (en) Analogs of neamine
PH16245A (en) Novel 3-acyloxymethyl-cephem compounds
JPS5534285A (en) Solution composition
GB1539733A (en) Preparation of 3-phenoxybenzaldehydes
JPS5259118A (en) Preparation of trichloromethyll trifluoromethyllbenzene
JPS5259119A (en) Preparation of trichloromethyll trifluoromethyllbenzene
IL50634A0 (en) Preparation of 2-amino-1-alcohols
JPS5260706A (en) Composition of ink
IL50150A (en) Preparation of 3-methoxymethyl-cephalosporins
JPS5273832A (en) Preparation of halogennitrobenzole
NZ181026A (en) Preparation of n-oxazol-2-ylcarboxamides
ZA762999B (en) Novel diureide compounds
ZA761382B (en) Improvements relating to substituted arylalkylamines
JPS51135228A (en) Preparation of leaffmold
CS189039B2 (en) Fundicide mixture